Pharma & Healthcare
Non-steroidal Anti-inflammatory Drugs (NSAID) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 18, 24
- ID: 554144
- Pages: 104
- Figures: 214
- Views: 1
The global market for Non-steroidal Anti-inflammatory Drugs (NSAID) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Non-steroidal Anti-inflammatory Drugs (NSAID), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Non-steroidal Anti-inflammatory Drugs (NSAID) by region & country, by Type, and by Application.
The Non-steroidal Anti-inflammatory Drugs (NSAID) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-steroidal Anti-inflammatory Drugs (NSAID).
Market Segmentation
By Company
Bayer
Ecotrin
Generic
St. Joseph
Elanco
Zoetis
Boehringer Ingelheim
Merial
Merck Animal Health
Segment by Type:
Salicylates
Propionic acid derivatives
Acetic acid derivatives
Enolic acid (Oxicam) derivatives
Anthranilic acid derivatives (Fenamates)
Selective COX-2 inhibitors (Coxibs)
Sulfonanilides
Segment by Application
Human
Animals
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Non-steroidal Anti-inflammatory Drugs (NSAID) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Non-steroidal Anti-inflammatory Drugs (NSAID) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Non-steroidal Anti-inflammatory Drugs (NSAID) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Non-steroidal Anti-inflammatory Drugs (NSAID), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Non-steroidal Anti-inflammatory Drugs (NSAID) by region & country, by Type, and by Application.
The Non-steroidal Anti-inflammatory Drugs (NSAID) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-steroidal Anti-inflammatory Drugs (NSAID).
Market Segmentation
By Company
Bayer
Ecotrin
Generic
St. Joseph
Elanco
Zoetis
Boehringer Ingelheim
Merial
Merck Animal Health
Segment by Type:
Salicylates
Propionic acid derivatives
Acetic acid derivatives
Enolic acid (Oxicam) derivatives
Anthranilic acid derivatives (Fenamates)
Selective COX-2 inhibitors (Coxibs)
Sulfonanilides
Segment by Application
Human
Animals
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Non-steroidal Anti-inflammatory Drugs (NSAID) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Non-steroidal Anti-inflammatory Drugs (NSAID) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Non-steroidal Anti-inflammatory Drugs (NSAID) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Product Introduction
1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Forecast
1.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value (2019-2030)
1.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume (2019-2030)
1.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price (2019-2030)
1.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Trends & Drivers
1.3.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Trends
1.3.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers & Opportunity
1.3.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Challenges
1.3.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Players Revenue Ranking (2023)
2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2019-2024)
2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Players Sales Volume Ranking (2023)
2.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Company Players (2019-2024)
2.5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price by Company (2019-2024)
2.6 Key Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Non-steroidal Anti-inflammatory Drugs (NSAID)
2.9 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competitive Analysis
2.9.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-steroidal Anti-inflammatory Drugs (NSAID) as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Salicylates
3.1.2 Propionic acid derivatives
3.1.3 Acetic acid derivatives
3.1.4 Enolic acid (Oxicam) derivatives
3.1.5 Anthranilic acid derivatives (Fenamates)
3.1.6 Selective COX-2 inhibitors (Coxibs)
3.1.7 Sulfonanilides
3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type
3.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, by Type (2019-2030)
3.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, by Type (%) (2019-2030)
3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Type
3.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, by Type (2019-2030)
3.3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, by Type (%) (2019-2030)
3.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Human
4.1.2 Animals
4.1.3 Others
4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application
4.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, by Application (2019-2030)
4.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, by Application (%) (2019-2030)
4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Application
4.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, by Application (2019-2030)
4.3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, by Application (%) (2019-2030)
4.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Region
5.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Region (2019-2024)
5.1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Region (2025-2030)
5.1.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Region (%), (2019-2030)
5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Region
5.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Region (2019-2024)
5.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Region (2025-2030)
5.2.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Region (%), (2019-2030)
5.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, 2019-2030
5.4.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, 2019-2030
5.5.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, 2019-2030
5.6.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, 2019-2030
5.7.2 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, 2019-2030
5.8.2 Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value
6.2.1 Key Countries/Regions Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, 2019-2030
6.2.2 Key Countries/Regions Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, 2019-2030
6.3.2 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, 2019-2030
6.4.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, 2019-2030
6.5.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, 2019-2030
6.6.2 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, 2019-2030
6.7.2 South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, 2019-2030
6.8.2 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, 2019-2030
6.9.2 India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Bayer
7.1.1 Bayer Company Information
7.1.2 Bayer Introduction and Business Overview
7.1.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
7.1.5 Bayer Recent Development
7.2 Ecotrin
7.2.1 Ecotrin Company Information
7.2.2 Ecotrin Introduction and Business Overview
7.2.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
7.2.5 Ecotrin Recent Development
7.3 Generic
7.3.1 Generic Company Information
7.3.2 Generic Introduction and Business Overview
7.3.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
7.3.5 Generic Recent Development
7.4 St. Joseph
7.4.1 St. Joseph Company Information
7.4.2 St. Joseph Introduction and Business Overview
7.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2019-2024)
7.4.4 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
7.4.5 St. Joseph Recent Development
7.5 Elanco
7.5.1 Elanco Company Information
7.5.2 Elanco Introduction and Business Overview
7.5.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
7.5.5 Elanco Recent Development
7.6 Zoetis
7.6.1 Zoetis Company Information
7.6.2 Zoetis Introduction and Business Overview
7.6.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
7.6.5 Zoetis Recent Development
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Company Information
7.7.2 Boehringer Ingelheim Introduction and Business Overview
7.7.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
7.7.5 Boehringer Ingelheim Recent Development
7.8 Merial
7.8.1 Merial Company Information
7.8.2 Merial Introduction and Business Overview
7.8.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
7.8.5 Merial Recent Development
7.9 Merck Animal Health
7.9.1 Merck Animal Health Company Information
7.9.2 Merck Animal Health Introduction and Business Overview
7.9.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
7.9.5 Merck Animal Health Recent Development
8 Industry Chain Analysis
8.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industrial Chain
8.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Model
8.5.2 Sales Channel
8.5.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Product Introduction
1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Forecast
1.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value (2019-2030)
1.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume (2019-2030)
1.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price (2019-2030)
1.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Trends & Drivers
1.3.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Trends
1.3.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers & Opportunity
1.3.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Challenges
1.3.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Players Revenue Ranking (2023)
2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2019-2024)
2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Players Sales Volume Ranking (2023)
2.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Company Players (2019-2024)
2.5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price by Company (2019-2024)
2.6 Key Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Non-steroidal Anti-inflammatory Drugs (NSAID)
2.9 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competitive Analysis
2.9.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-steroidal Anti-inflammatory Drugs (NSAID) as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Salicylates
3.1.2 Propionic acid derivatives
3.1.3 Acetic acid derivatives
3.1.4 Enolic acid (Oxicam) derivatives
3.1.5 Anthranilic acid derivatives (Fenamates)
3.1.6 Selective COX-2 inhibitors (Coxibs)
3.1.7 Sulfonanilides
3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type
3.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, by Type (2019-2030)
3.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, by Type (%) (2019-2030)
3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Type
3.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, by Type (2019-2030)
3.3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, by Type (%) (2019-2030)
3.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Human
4.1.2 Animals
4.1.3 Others
4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application
4.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, by Application (2019-2030)
4.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, by Application (%) (2019-2030)
4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Application
4.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, by Application (2019-2030)
4.3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, by Application (%) (2019-2030)
4.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Region
5.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Region (2019-2024)
5.1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Region (2025-2030)
5.1.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Region (%), (2019-2030)
5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Region
5.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Region (2019-2024)
5.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Region (2025-2030)
5.2.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Region (%), (2019-2030)
5.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, 2019-2030
5.4.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, 2019-2030
5.5.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, 2019-2030
5.6.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, 2019-2030
5.7.2 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, 2019-2030
5.8.2 Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value
6.2.1 Key Countries/Regions Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, 2019-2030
6.2.2 Key Countries/Regions Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, 2019-2030
6.3.2 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, 2019-2030
6.4.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, 2019-2030
6.5.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, 2019-2030
6.6.2 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, 2019-2030
6.7.2 South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, 2019-2030
6.8.2 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, 2019-2030
6.9.2 India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Bayer
7.1.1 Bayer Company Information
7.1.2 Bayer Introduction and Business Overview
7.1.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
7.1.5 Bayer Recent Development
7.2 Ecotrin
7.2.1 Ecotrin Company Information
7.2.2 Ecotrin Introduction and Business Overview
7.2.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
7.2.5 Ecotrin Recent Development
7.3 Generic
7.3.1 Generic Company Information
7.3.2 Generic Introduction and Business Overview
7.3.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
7.3.5 Generic Recent Development
7.4 St. Joseph
7.4.1 St. Joseph Company Information
7.4.2 St. Joseph Introduction and Business Overview
7.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2019-2024)
7.4.4 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
7.4.5 St. Joseph Recent Development
7.5 Elanco
7.5.1 Elanco Company Information
7.5.2 Elanco Introduction and Business Overview
7.5.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
7.5.5 Elanco Recent Development
7.6 Zoetis
7.6.1 Zoetis Company Information
7.6.2 Zoetis Introduction and Business Overview
7.6.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
7.6.5 Zoetis Recent Development
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Company Information
7.7.2 Boehringer Ingelheim Introduction and Business Overview
7.7.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
7.7.5 Boehringer Ingelheim Recent Development
7.8 Merial
7.8.1 Merial Company Information
7.8.2 Merial Introduction and Business Overview
7.8.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
7.8.5 Merial Recent Development
7.9 Merck Animal Health
7.9.1 Merck Animal Health Company Information
7.9.2 Merck Animal Health Introduction and Business Overview
7.9.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
7.9.5 Merck Animal Health Recent Development
8 Industry Chain Analysis
8.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industrial Chain
8.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Model
8.5.2 Sales Channel
8.5.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Trends
Table 2. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers & Opportunity
Table 3. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Challenges
Table 4. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints
Table 5. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Company (2019-2024)
Table 7. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Company (2019-2024) & (USD/Unit)
Table 10. Key Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Non-steroidal Anti-inflammatory Drugs (NSAID)
Table 13. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-steroidal Anti-inflammatory Drugs (NSAID) as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2019-2024) & (USD/Unit)
Table 27. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2025-2030) & (USD/Unit)
Table 28. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2025-2030) & (USD/Unit)
Table 40. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Region (2019-2024) & (%)
Table 44. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Region (2025-2030) & (%)
Table 45. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Region (2019-2024) & (%)
Table 49. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Region (2025-2030) & (%)
Table 50. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price by Region (2019-2024) & (USD/Unit)
Table 51. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price by Region (2025-2030) & (USD/Unit)
Table 52. Key Countries/Regions Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, (2025-2030) & (K Units)
Table 57. Bayer Company Information
Table 58. Bayer Introduction and Business Overview
Table 59. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 61. Bayer Recent Development
Table 62. Ecotrin Company Information
Table 63. Ecotrin Introduction and Business Overview
Table 64. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 65. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 66. Ecotrin Recent Development
Table 67. Generic Company Information
Table 68. Generic Introduction and Business Overview
Table 69. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 70. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 71. Generic Recent Development
Table 72. St. Joseph Company Information
Table 73. St. Joseph Introduction and Business Overview
Table 74. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 75. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 76. St. Joseph Recent Development
Table 77. Elanco Company Information
Table 78. Elanco Introduction and Business Overview
Table 79. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 80. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 81. Elanco Recent Development
Table 82. Zoetis Company Information
Table 83. Zoetis Introduction and Business Overview
Table 84. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 86. Zoetis Recent Development
Table 87. Boehringer Ingelheim Company Information
Table 88. Boehringer Ingelheim Introduction and Business Overview
Table 89. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 91. Boehringer Ingelheim Recent Development
Table 92. Merial Company Information
Table 93. Merial Introduction and Business Overview
Table 94. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 96. Merial Recent Development
Table 97. Merck Animal Health Company Information
Table 98. Merck Animal Health Introduction and Business Overview
Table 99. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 100. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 101. Merck Animal Health Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Non-steroidal Anti-inflammatory Drugs (NSAID) Downstream Customers
Table 105. Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-steroidal Anti-inflammatory Drugs (NSAID) Product Picture
Figure 2. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume (2019-2030) & (K Units)
Figure 5. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price (2019-2030) & (USD/Unit)
Figure 6. Non-steroidal Anti-inflammatory Drugs (NSAID) Report Years Considered
Figure 7. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue in 2023
Figure 10. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Salicylates Picture
Figure 12. Propionic acid derivatives Picture
Figure 13. Acetic acid derivatives Picture
Figure 14. Enolic acid (Oxicam) derivatives Picture
Figure 15. Anthranilic acid derivatives (Fenamates) Picture
Figure 16. Selective COX-2 inhibitors (Coxibs) Picture
Figure 17. Sulfonanilides Picture
Figure 18. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value Market Share by Type, 2023 & 2030
Figure 20. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 21. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Market Share by Type, 2023 & 2030
Figure 22. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2019-2030) & (USD/Unit)
Figure 23. Product Picture of Human
Figure 24. Product Picture of Animals
Figure 25. Product Picture of Others
Figure 26. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 27. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value Market Share by Application, 2023 & 2030
Figure 28. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 29. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Market Share by Application, 2023 & 2030
Figure 30. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2019-2030) & (USD/Unit)
Figure 31. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value (2019-2030) & (US$ Million)
Figure 32. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Country (%), 2023 VS 2030
Figure 33. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value (2019-2030) & (US$ Million)
Figure 34. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Country (%), 2023 VS 2030
Figure 35. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Country (%), 2023 VS 2030
Figure 37. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value (2019-2030) & (US$ Million)
Figure 38. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Country (%), 2023 VS 2030
Figure 39. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Country (%), 2023 VS 2030
Figure 41. Key Countries/Regions Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value (%), (2019-2030)
Figure 42. Key Countries/Regions Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume (%), (2019-2030)
Figure 43. United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, (2019-2030) & (US$ Million)
Figure 44. United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (%), 2023 VS 2030
Figure 45. United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application (%), 2023 VS 2030
Figure 46. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, (2019-2030) & (US$ Million)
Figure 47. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (%), 2023 VS 2030
Figure 48. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application (%), 2023 VS 2030
Figure 49. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, (2019-2030) & (US$ Million)
Figure 50. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (%), 2023 VS 2030
Figure 51. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application (%), 2023 VS 2030
Figure 52. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, (2019-2030) & (US$ Million)
Figure 53. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (%), 2023 VS 2030
Figure 54. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application (%), 2023 VS 2030
Figure 55. South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, (2019-2030) & (US$ Million)
Figure 56. South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (%), 2023 VS 2030
Figure 57. South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application (%), 2023 VS 2030
Figure 58. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, (2019-2030) & (US$ Million)
Figure 59. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (%), 2023 VS 2030
Figure 60. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application (%), 2023 VS 2030
Figure 61. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, (2019-2030) & (US$ Million)
Figure 62. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (%), 2023 VS 2030
Figure 63. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application (%), 2023 VS 2030
Figure 64. Non-steroidal Anti-inflammatory Drugs (NSAID) Industrial Chain
Figure 65. Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Cost Structure
Figure 66. Channels of Distribution (Direct Sales, and Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Table 1. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Trends
Table 2. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers & Opportunity
Table 3. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Challenges
Table 4. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints
Table 5. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Company (2019-2024)
Table 7. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Company (2019-2024) & (USD/Unit)
Table 10. Key Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Non-steroidal Anti-inflammatory Drugs (NSAID)
Table 13. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-steroidal Anti-inflammatory Drugs (NSAID) as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2019-2024) & (USD/Unit)
Table 27. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2025-2030) & (USD/Unit)
Table 28. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2025-2030) & (USD/Unit)
Table 40. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Region (2019-2024) & (%)
Table 44. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Region (2025-2030) & (%)
Table 45. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Region (2019-2024) & (%)
Table 49. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Region (2025-2030) & (%)
Table 50. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price by Region (2019-2024) & (USD/Unit)
Table 51. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price by Region (2025-2030) & (USD/Unit)
Table 52. Key Countries/Regions Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, (2025-2030) & (K Units)
Table 57. Bayer Company Information
Table 58. Bayer Introduction and Business Overview
Table 59. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 61. Bayer Recent Development
Table 62. Ecotrin Company Information
Table 63. Ecotrin Introduction and Business Overview
Table 64. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 65. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 66. Ecotrin Recent Development
Table 67. Generic Company Information
Table 68. Generic Introduction and Business Overview
Table 69. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 70. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 71. Generic Recent Development
Table 72. St. Joseph Company Information
Table 73. St. Joseph Introduction and Business Overview
Table 74. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 75. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 76. St. Joseph Recent Development
Table 77. Elanco Company Information
Table 78. Elanco Introduction and Business Overview
Table 79. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 80. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 81. Elanco Recent Development
Table 82. Zoetis Company Information
Table 83. Zoetis Introduction and Business Overview
Table 84. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 86. Zoetis Recent Development
Table 87. Boehringer Ingelheim Company Information
Table 88. Boehringer Ingelheim Introduction and Business Overview
Table 89. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 91. Boehringer Ingelheim Recent Development
Table 92. Merial Company Information
Table 93. Merial Introduction and Business Overview
Table 94. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 96. Merial Recent Development
Table 97. Merck Animal Health Company Information
Table 98. Merck Animal Health Introduction and Business Overview
Table 99. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 100. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 101. Merck Animal Health Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Non-steroidal Anti-inflammatory Drugs (NSAID) Downstream Customers
Table 105. Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-steroidal Anti-inflammatory Drugs (NSAID) Product Picture
Figure 2. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume (2019-2030) & (K Units)
Figure 5. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price (2019-2030) & (USD/Unit)
Figure 6. Non-steroidal Anti-inflammatory Drugs (NSAID) Report Years Considered
Figure 7. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue in 2023
Figure 10. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Salicylates Picture
Figure 12. Propionic acid derivatives Picture
Figure 13. Acetic acid derivatives Picture
Figure 14. Enolic acid (Oxicam) derivatives Picture
Figure 15. Anthranilic acid derivatives (Fenamates) Picture
Figure 16. Selective COX-2 inhibitors (Coxibs) Picture
Figure 17. Sulfonanilides Picture
Figure 18. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value Market Share by Type, 2023 & 2030
Figure 20. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 21. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Market Share by Type, 2023 & 2030
Figure 22. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2019-2030) & (USD/Unit)
Figure 23. Product Picture of Human
Figure 24. Product Picture of Animals
Figure 25. Product Picture of Others
Figure 26. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 27. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value Market Share by Application, 2023 & 2030
Figure 28. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 29. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Market Share by Application, 2023 & 2030
Figure 30. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2019-2030) & (USD/Unit)
Figure 31. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value (2019-2030) & (US$ Million)
Figure 32. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Country (%), 2023 VS 2030
Figure 33. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value (2019-2030) & (US$ Million)
Figure 34. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Country (%), 2023 VS 2030
Figure 35. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Country (%), 2023 VS 2030
Figure 37. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value (2019-2030) & (US$ Million)
Figure 38. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Country (%), 2023 VS 2030
Figure 39. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Country (%), 2023 VS 2030
Figure 41. Key Countries/Regions Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value (%), (2019-2030)
Figure 42. Key Countries/Regions Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume (%), (2019-2030)
Figure 43. United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, (2019-2030) & (US$ Million)
Figure 44. United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (%), 2023 VS 2030
Figure 45. United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application (%), 2023 VS 2030
Figure 46. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, (2019-2030) & (US$ Million)
Figure 47. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (%), 2023 VS 2030
Figure 48. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application (%), 2023 VS 2030
Figure 49. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, (2019-2030) & (US$ Million)
Figure 50. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (%), 2023 VS 2030
Figure 51. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application (%), 2023 VS 2030
Figure 52. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, (2019-2030) & (US$ Million)
Figure 53. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (%), 2023 VS 2030
Figure 54. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application (%), 2023 VS 2030
Figure 55. South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, (2019-2030) & (US$ Million)
Figure 56. South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (%), 2023 VS 2030
Figure 57. South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application (%), 2023 VS 2030
Figure 58. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, (2019-2030) & (US$ Million)
Figure 59. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (%), 2023 VS 2030
Figure 60. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application (%), 2023 VS 2030
Figure 61. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, (2019-2030) & (US$ Million)
Figure 62. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Type (%), 2023 VS 2030
Figure 63. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Application (%), 2023 VS 2030
Figure 64. Non-steroidal Anti-inflammatory Drugs (NSAID) Industrial Chain
Figure 65. Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Cost Structure
Figure 66. Channels of Distribution (Direct Sales, and Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232